Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
101 East Kennedy Boulevard, 41st Floor, Bank of American Plaza, Tampa, FL, 33602, US
Catalent is a leading CDMO championing the missions that help people live better and healthier lives. Catalent provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. Catalent tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing.
When a biologic drug is being studied in a clinical trial, the sponsor may want to compare the investigational product to a current standard of care, known as a comparator drug. In other cases, a co-medication may need to be dosed along with the study drug. Sourcing commercially available branded biologics can be challenging for […]
Released By Catalent
Along with a discussion, examples of real-life tactical and operational decisions involved in the integrated approach to drug development will be presented.
What are some key supply considerations that sponsors need to keep in mind when planning a DCT? What should they look out for when choosing a supply partner?
This webinar on May 1 will explore several alternative clinical supply models, use cases and identify key considerations when adopting one of these models.
As the cell and gene therapy market continues to grow, analytical science will play an increasingly important role.
This ebook analyzes how to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care.
The oral solid dose market is robust due to demand for specialized dosage forms such as controlled release, pediatric and geriatric delivery vehicles.
The constant drive for efficiency has become an essential element of any business process, across all industries.
Cell and gene therapies represent the next-generation of therapeutics.
The Importance of Risk Assessment and the Role of Evaluating Elemental Impurities
Analytical technology and processes are evolving as the biologics industry continues to grow.
As the biologics market grows, the demand increases for development and manufacturing capabilities.
Catheric to use Catalent’s iPSC line for the manufacture and commercialization of iPSC-derived Chimeric Antigen Receptor Natural Killer (CAR-NK) cell therapies.
By: Charlie Sternberg
GelMEDIX gains access to Catalent’s proprietary, off-the-shelf, GMP-compliant iPSC lines and Catalent’s GMP iPSC and iPSC-derived cell therapy manufacturing capabilities.
Underscores the company’s commitment to delivering ‘unparalleled’ customer service.
Partnership expected to improve yield and upgrade analytical methods ahead of clinical use and regulatory submissions.
Proprietary algorithm achieved a preset pharmacokinetic target during an ongoing modified-release formulation study.
The exclusive global licensing agreement covers 1ST-104 and includes upfront, milestone and royalty payments.
Ground-mounted plant will generate about 3,950 MWh annually.
Pharma companies back Secaro and ERM initiative to cut industrial heat emissions.
The strategic collaboration was agreed upon with an undisclosed biopharmaceutical company.
By: Patrick Lavery
New platform streamlines small-scale virus filtration for biopharma and gene therapy workflows.
Offers support to pharmaceutical and nutraceutical developers from the initial idea through to series production.
Shaywitz brings two decades of experience in the biopharmaceutical industry, most recently at BridgeBio.
The agreement extends manufacturing commitments through 2033 and pushes Samsung Biologics’ cumulative contract value above $21.9 billion.
LeAnne Bloedon will be Executive Vice President, Clinical Development and Operations, and Kevin Schutz will be Vice President, Regulatory Affairs.
The 21,000-square-foot facility will train students for careers in aseptic and sterile pharmaceutical manufacturing.
The CDMO is adding new property, aseptic fill-finish lines, packaging capacity, and analytical capabilities at its Caponago site near Milan.
Serialization planning, data visibility and partner connectivity can help biopharma companies prepare complex therapies for commercial scale.
By: Joe Lipari
Munschauer has been CMO at three previous biopharmaceutical companies, most recently Emalex Biosciences.
Small molecules remain central to pharmaceutical innovation, but the development process is changing.
Released By Lonza
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
